{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:48:55Z","timestamp":1765885735231},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["R21 CA131927"],"award-info":[{"award-number":["R21 CA131927"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.leukres.2010.10.007","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T09:28:06Z","timestamp":1289381286000},"page":"904-908","source":"Crossref","is-referenced-by-count":15,"title":["Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromes"],"prefix":"10.1016","volume":"35","author":[{"given":"Rong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cary P.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Maggiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Halene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela R.","family":"Soulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azra","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Galili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.10.007_bib0005","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.007_bib0010","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/cncr.22570","article-title":"Myelodysplastic syndromes: incidence and survival in the United States","volume":"109","author":"Ma","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2010.10.007_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2008-01-134858","article-title":"Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001\u20132004, using data from the NAACCR and SEER programs","volume":"112","author":"Rollison","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.007_bib0020","first-page":"1997","article-title":"Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia","volume":"100","author":"Sierra","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.007_bib0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1053\/j.seminhematol.2007.10.004","article-title":"Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes","volume":"45","author":"Hellstrom-Lindberg","year":"2008","journal-title":"Semin Hematol"},{"key":"10.1016\/j.leukres.2010.10.007_bib0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/CCO.0b013e328313699c","article-title":"Demethylating agents in myeloid malignancies","volume":"20","author":"Garcia-Manero","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.leukres.2010.10.007_bib0035","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1200\/JCO.2002.04.117","article-title":"Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B","volume":"20","author":"Silverman","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.10.007_bib0040","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1200\/JCO.2005.05.4346","article-title":"Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B","volume":"24","author":"Silverman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.10.007_bib0045","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.21792","article-title":"Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study","volume":"106","author":"Kantarjian","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2010.10.007_bib0050","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1200\/JCO.2008.19.6550","article-title":"Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial","volume":"27","author":"Steensma","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.10.007_bib0055","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1200\/JCO.2002.04.044","article-title":"Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study","volume":"20","author":"Kornblith","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.10.007_bib0060","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1200\/JCO.2009.23.8329","article-title":"Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia","volume":"28","author":"Fenaux","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.10.007_bib0065","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1200\/JCO.1997.15.7.2644","article-title":"Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors","volume":"15","author":"Mitchell","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.10.007_bib0070","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/1097-0142(20001201)89:11<2202::AID-CNCR8>3.0.CO;2-L","article-title":"Effects of health insurance and race on breast carcinoma treatments and outcomes","volume":"89","author":"Roetzheim","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2010.10.007_bib0075","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2002.07.142","article-title":"Impact of referral patterns on the use of chemotherapy for lung cancer","volume":"20","author":"Earle","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.10.007_bib0080","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1200\/JCO.2004.00.1297","article-title":"Insurance status and the use of guideline therapy in the treatment of selected cancers","volume":"23","author":"Harlan","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.10.007_bib0085","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2105\/AJPH.2004.053579","article-title":"The roles of teaching hospitals, insurance status, and race\/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida","volume":"96","author":"Richardson","year":"2006","journal-title":"Am J Publ Health"},{"key":"10.1016\/j.leukres.2010.10.007_bib0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/CA.2007.0011","article-title":"Association of insurance with cancer care utilization and outcomes","volume":"58","author":"Ward","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.leukres.2010.10.007_bib0095","first-page":"785","article-title":"Delayed radiotherapy for breast cancer patients in integrated delivery systems","volume":"15","author":"Gold","year":"2009","journal-title":"Am J Manage Care"},{"key":"10.1016\/j.leukres.2010.10.007_bib0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.lungcan.2008.05.003","article-title":"Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States","volume":"63","author":"Lang","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.leukres.2010.10.007_bib0105","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/MLR.0b013e31819a5b2b","article-title":"Factors associated with immunotherapy use among newly diagnosed cancer patients","volume":"47","author":"Shih","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.leukres.2010.10.007_bib0110","doi-asserted-by":"crossref","first-page":"IV-3","DOI":"10.1097\/00005650-200208001-00002","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.leukres.2010.10.007_bib0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005650-200203000-00004","article-title":"Construct validity of medicare chemotherapy claims: the case of 5FU","volume":"40","author":"Lamont","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.leukres.2010.10.007_bib0120","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/jnci\/dji189","article-title":"Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants","volume":"97","author":"Lamont","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.leukres.2010.10.007_bib0125","series-title":"International classification of diseases for oncology","year":"2000"},{"key":"10.1016\/j.leukres.2010.10.007_bib0130","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","article-title":"Risks of myeloid malignancies in patients with autoimmune conditions","volume":"100","author":"Anderson","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.leukres.2010.10.007_bib0135","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1158\/1055-9965.EPI-08-0408","article-title":"Hematopoietic malignancies associated with viral and alcoholic hepatitis","volume":"17","author":"Anderson","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.leukres.2010.10.007_bib0140","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/aje\/kwp074","article-title":"Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort","volume":"169","author":"Ma","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.leukres.2010.10.007_bib0145","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s10552-009-9362-7","article-title":"Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States","volume":"20","author":"Wang","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.leukres.2010.10.007_bib0150","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.leukres.2009.02.005","article-title":"Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes","volume":"33","author":"Wang","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2010.10.007_bib0155","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/01.mlr.0000124254.88292.a1","article-title":"Comparison of comorbidity indices for patients with head and neck cancer","volume":"42","author":"Piccirillo","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.leukres.2010.10.007_bib0160","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1378\/chest.07-1007","article-title":"Trends in end-of-life ICU use among older adults with advanced lung cancer","volume":"133","author":"Sharma","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.leukres.2010.10.007_bib0165","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1001\/jama.296.22.2683","article-title":"Survival associated with treatment vs observation of localized prostate cancer in elderly men","volume":"296","author":"Wong","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.leukres.2010.10.007_bib0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.leukres.2010.10.007_bib0175","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.leukres.2010.10.007_bib0180","doi-asserted-by":"crossref","first-page":"IV-19","DOI":"10.1097\/00005650-200208001-00003","article-title":"Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations","volume":"40","author":"Bach","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.leukres.2010.10.007_bib0185","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/jnci\/djn349","article-title":"Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys","volume":"100","author":"Sekeres","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.leukres.2010.10.007_bib0190","series-title":"ASH Annual Meeting Abstracts, vol. 114","article-title":"Patterns of hypomethylating agent and transfusion use in myelodysplastic syndrome: a claims database study","author":"Hatoum","year":"2009"},{"key":"10.1016\/j.leukres.2010.10.007_bib0195","doi-asserted-by":"crossref","unstructured":"Van Bennekom C, Abel G, Anderson T, Stone R, Kaufman D. Patterns of treatment among patients with recently-diagnosed myelodysplastic syndromes in a national registry, 2006\u20132008. American Society of Hematology Annual Meeting. San Francisco: Blood; 2008.","DOI":"10.1182\/blood.V112.11.876.876"},{"key":"10.1016\/j.leukres.2010.10.007_bib0200","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.hoc.2010.02.012","article-title":"Practical recommendations for hypomethylating agent therapy of patients with myelodysplastic syndromes","volume":"24","author":"Steensma","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.leukres.2010.10.007_bib0205","first-page":"1513","article-title":"Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches","volume":"91","author":"Deschler","year":"2006","journal-title":"Haematologica"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610004820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610004820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T17:35:37Z","timestamp":1592069737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610004820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0145212610004820"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.10.007","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}